Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Actos · 4.3 · - hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - cardiac failure
Eintrag öffnenActraphane · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenActraphane · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenActrapid · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAdasuve · 4.5 · Co-administration of loxapine and adrenaline may cause worsening of hypotension (see section 4.4).
Eintrag öffnenAdasuve · 4.5 · Co-administration of loxapine and adrenaline may cause worsening of hypotension (see section 4.4).
Eintrag öffnenAdcetris · 4.3 · Combined use of bleomycin and ADCETRIS causes pulmonary toxicity (see section 4.5).
Eintrag öffnenAdcetris · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAdcetris · 4.8 · 14 The safety data in patients retreated with ADCETRIS (SGN35-006, see section 5.1) were consistent with those
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · 23 patients already on bosentan therapy has not been conclusively demonstrated (see sections 4.4 and 5.1). Tad
Eintrag öffnenAdempas · 4.3 · - Co-administration with PDE5 inhibitors (such as sildenafil, tadalafil, vardenafil) (see sections 4.2 and 4.5
Eintrag öffnenAdempas · 4.3 · - Co-administration with PDE5 inhibitors (such as sildenafil, tadalafil, vardenafil) (see sections 4.2 and 4.5
Eintrag öffnenAdempas · 4.5 · 9 Smoking In cigarette smokers riociguat exposure is reduced by 50-60% (see section 5.2). Therefore, patients
Eintrag öffnenAdempas · 4.5 · Patients must not get pregnant during riociguat therapy (see section 4.3). Riociguat (2.5 mg 3 times daily) di
Eintrag öffnenAdempas · 4.5 · Patients must not get pregnant during riociguat therapy (see section 4.3). Riociguat (2.5 mg 3 times daily) di
Eintrag öffnenAdempas · 4.5 · Smoking In cigarette smokers riociguat exposure is reduced by 50-60% (see section 5.2). Therefore, patients ar
Eintrag öffnenAdempas · 4.8 · 11 to 16 weeks (see section 4.2), followed by an optional long-term extension phase. Most common adverse react
Eintrag öffnenAdenuric · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see also section 4
Eintrag öffnen